Director at Jupiter Neurosciences (JUNS) receives 100K stock options

Rhea-AI Filing Summary

Jupiter Neurosciences director Holger Weis received a grant of stock options covering 100,000 shares of common stock. The options have an exercise price of $0.2783 per share and expire on June 2, 2036. They were granted under the company’s 2025 Equity Incentive Plan and vest over three years starting on September 2, 2026, in equal quarterly installments, subject to continued service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Weis Holger

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	100,000	$0.00	--

Holdings After Transaction: Stock Option — 100,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 100,000 options Exercise price: $0.2783 per share Underlying shares: 100,000 shares +3 more

6 metrics

Options granted 100,000 options Stock option award to director Holger Weis

Exercise price $0.2783 per share Strike price for the granted stock options

Underlying shares 100,000 shares Common stock underlying the options

Option expiration June 2, 2036 Expiration date of the stock options

Vesting period 3 years Quarterly vesting starting September 2, 2026

Shares following transaction 100,000 options Total derivative holdings after the grant

Key Terms

Stock Option, 2025 Equity Incentive Plan, vest over three years, expiration date

4 terms

Stock Option financial

"security_title: "Stock Option""

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

2025 Equity Incentive Plan financial

"The options were granted under the Issuer's 2025 Equity Incentive Plan."

vest over three years financial

"The options vest over three years commencing from September 2, 2026"

expiration date financial

"expiration_date: "2036-06-02T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weis Holger

(Last) (First) (Middle)

C/O JUPITER NEUROSCIENCES, INC.

1001 NORTH US HYWAY 1, SUITE 504

(Street)

JUPITER FLORIDA 33477

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JUPITER NEUROSCIENCES, INC. [ JUNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.2783	06/02/2026		A		100,000		(1)	06/02/2036	Common Stock	100,000	$0	100,000	D

Explanation of Responses:

1. The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date.

	/s/ Holger Weis	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Jupiter Neurosciences (JUNS) report for Holger Weis?

Jupiter Neurosciences reported that director Holger Weis received a grant of stock options for 100,000 shares. These options were issued under the 2025 Equity Incentive Plan as compensation rather than an open-market purchase or sale of existing shares.

What is the exercise price of the new JUNS stock options granted to Holger Weis?

The stock options granted to Holger Weis have an exercise price of $0.2783 per share. This means he can buy Jupiter Neurosciences common stock at $0.2783 per share once the options vest, subject to the plan’s terms and his continued service.

How do the Jupiter Neurosciences (JUNS) options granted to Holger Weis vest?

The options granted to Holger Weis vest over three years in equal quarterly installments. Vesting begins on September 2, 2026, and each quarterly tranche requires that he continue providing service to Jupiter Neurosciences through the relevant vesting date.

When do Holger Weis’s JUNS stock options expire?

Holger Weis’s stock options in Jupiter Neurosciences expire on June 2, 2036. If the options are not exercised by that expiration date, they will lapse, and he will no longer have the right to purchase shares at the $0.2783 exercise price.

How many Jupiter Neurosciences (JUNS) options does Holger Weis hold after this grant?

After this grant, Holger Weis holds 100,000 stock options in Jupiter Neurosciences. These options correspond to 100,000 underlying shares of common stock, all subject to the three-year quarterly vesting schedule starting on September 2, 2026.